(WELL) Welltower - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US95040Q1040
Senior Housing, Wellness Communities, Real Estate
Dividends
| Dividend Yield | 1.51% |
| Yield on Cost 5y | 5.10% |
| Yield CAGR 5y | -1.32% |
| Payout Consistency | 97.5% |
| Payout Ratio | 1.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.1% |
| Value at Risk 5%th | 41.0% |
| Relative Tail Risk | -0.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.71 |
| Alpha | 39.50 |
| CAGR/Max DD | 3.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.421 |
| Beta | 0.320 |
| Beta Downside | 0.460 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.05% |
| Mean DD | 2.59% |
| Median DD | 1.84% |
Description: WELL Welltower December 02, 2025
Welltower Inc. (NYSE: WELL) is an S&P 500-listed REIT that concentrates on senior-focused rental housing and wellness communities across the United States, United Kingdom, and Canada. The company describes itself as a hybrid “operating company in a real-estate wrapper,” leveraging data-science-driven capital allocation and the proprietary Welltower Business System to generate long-term per-share growth for shareholders.
Key operational metrics (as of Q3 2024) show an occupancy rate of roughly 94% and adjusted funds from operations (AFFO) of $1.23 per share for FY 2024, reflecting a 7% year-over-year increase. The pipeline includes more than 30 new or redeveloped communities slated for completion by 2026, primarily in “micro-markets” with strong senior population growth; the U.S. 65-plus cohort is projected to rise from 56 million in 2023 to 78 million by 2035, underpinning demand. A sector-wide driver is the prevailing low-interest-rate environment, which supports REIT valuation through compressed cap rates, though any upward shift in rates could pressure pricing and financing costs.
For a deeper quantitative breakdown and scenario analysis, the ValueRay platform offers a concise, data-rich view of WELL’s valuation dynamics.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (958.0m TTM) > 0 and > 6% of Revenue (6% = 588.6m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 91.01% (prev 73.19%; Δ 17.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 2.79b > Net Income 958.0m (YES >=105%, WARN >=100%) |
| Net Debt (11.36b) to EBITDA (3.50b) ratio: 3.24 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (685.4m) change vs 12m ago 10.85% (target <= -2.0% for YES) |
| Gross Margin 39.21% (prev 39.38%; Δ -0.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 18.09% (prev 15.02%; Δ 3.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.49 (EBITDA TTM 3.50b / Interest Expense TTM 602.6m) >= 6 (WARN >= 3) |
Altman Z'' 0.27
| (A) 0.15 = (Total Current Assets 10.96b - Total Current Liabilities 2.03b) / Total Assets 59.50b |
| (B) -0.15 = Retained Earnings (Balance) -8.75b / Total Assets 59.50b |
| (C) 0.03 = EBIT TTM 1.50b / Avg Total Assets 54.23b |
| (D) -0.40 = Book Value of Equity -8.28b / Total Liabilities 20.48b |
| Total Rating: 0.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.03
| 1. Piotroski 3.0pt |
| 2. FCF Yield 1.83% |
| 3. FCF Margin 28.26% |
| 4. Debt/Equity 0.47 |
| 5. Debt/Ebitda 3.24 |
| 6. ROIC - WACC (= -3.65)% |
| 7. RoE 2.73% |
| 8. Rev. Trend 97.75% |
| 9. EPS Trend 74.70% |
What is the price of WELL shares?
As of December 13, 2025, the stock is trading at USD 186.73 with a total of 4,183,041 shares traded.
Over the past week, the price has changed by -8.60%, over one month by -2.56%, over three months by +10.84% and over the past year by +47.93%.
Over the past week, the price has changed by -8.60%, over one month by -2.56%, over three months by +10.84% and over the past year by +47.93%.
Is WELL a buy, sell or hold?
Welltower has received a consensus analysts rating of 4.30.
Therefore, it is recommended to buy WELL.
- Strong Buy: 10
- Buy: 6
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the WELL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 208.8 | 11.8% |
| Analysts Target Price | 208.8 | 11.8% |
| ValueRay Target Price | 265.6 | 42.2% |
WELL Fundamental Data Overview December 06, 2025
Market Cap USD = 139.92b (139.92b USD * 1.0 USD.USD)
P/E Trailing = 140.6
P/E Forward = 85.4701
P/S = 14.1223
P/B = 3.5757
P/EG = 3.6218
Beta = 0.853
Revenue TTM = 9.81b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 3.50b USD
Long Term Debt = 16.85b USD (from longTermDebt, last quarter)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 151.28b USD (139.92b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.50b / Interest Expense TTM 602.6m)
FCF Yield = 1.83% (FCF TTM 2.77b / Enterprise Value 151.28b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.54 (Enterprise Value 151.28b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.44b (EBIT 1.50b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.24 (Net Debt 11.36b / EBITDA 3.50b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.61% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.89% (EBIT 1.50b / Capital Employed (Equity 35.14b + L.T.Debt 16.85b))
RoIC = 2.81% (NOPAT 1.44b / Invested Capital 51.15b)
WACC = 6.46% (E(139.92b)/V(158.09b) * Re(7.19%) + D(18.16b)/V(158.09b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 80.97% ; FCFE base≈2.42b ; Y1≈2.88b ; Y5≈4.55b
Fair Price DCF = 113.4 (DCF Value 77.85b / Shares Outstanding 686.3m; 5y FCF grow 20.56% → 3.0% )
EPS Correlation: 74.70 | EPS CAGR: 35.84% | SUE: -0.77 | # QB: 0
Revenue Correlation: 97.75 | Revenue CAGR: 21.45% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=+0.127 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=2.43 | Chg30d=-0.120 | Revisions Net=+0 | Growth EPS=+42.1% | Growth Revenue=+18.9%
P/E Trailing = 140.6
P/E Forward = 85.4701
P/S = 14.1223
P/B = 3.5757
P/EG = 3.6218
Beta = 0.853
Revenue TTM = 9.81b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 3.50b USD
Long Term Debt = 16.85b USD (from longTermDebt, last quarter)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 151.28b USD (139.92b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.50b / Interest Expense TTM 602.6m)
FCF Yield = 1.83% (FCF TTM 2.77b / Enterprise Value 151.28b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.54 (Enterprise Value 151.28b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.44b (EBIT 1.50b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.24 (Net Debt 11.36b / EBITDA 3.50b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.61% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.89% (EBIT 1.50b / Capital Employed (Equity 35.14b + L.T.Debt 16.85b))
RoIC = 2.81% (NOPAT 1.44b / Invested Capital 51.15b)
WACC = 6.46% (E(139.92b)/V(158.09b) * Re(7.19%) + D(18.16b)/V(158.09b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 80.97% ; FCFE base≈2.42b ; Y1≈2.88b ; Y5≈4.55b
Fair Price DCF = 113.4 (DCF Value 77.85b / Shares Outstanding 686.3m; 5y FCF grow 20.56% → 3.0% )
EPS Correlation: 74.70 | EPS CAGR: 35.84% | SUE: -0.77 | # QB: 0
Revenue Correlation: 97.75 | Revenue CAGR: 21.45% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=+0.127 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=2.43 | Chg30d=-0.120 | Revisions Net=+0 | Growth EPS=+42.1% | Growth Revenue=+18.9%
Additional Sources for WELL Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle